Duke Cancer Network is a clinical research site located in Durham, North Carolina, United States 27713.
Crixeo Clinical Trials Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.
Duke Cancer Network has participated in 4 clinical trials with 3 currently active.
Therapeutic areas: Advanced Breast Cancer, Advanced Prostate Cancer, Advanced Lung Cancer.
Sponsors: Duke University, Novartis Pharmaceuticals, Prostate Cancer Clinical Trials Consortium.
Trust Score: 70/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Duke Cancer Network has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Duke Cancer Network has 4 clinical trials on record, with 3 currently active. Their work covers Advanced Breast Cancer, Advanced Prostate Cancer, Advanced Lung Cancer.
Duke Cancer Network has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.